Jeremy Caldwell

Jeremy Caldwell is an accomplished professional with extensive experience in the biotechnology and venture capital sectors. Currently serving as a Board Member at Sardona Therapeutics and as a Partner at Red Tree Venture Capital since October 2023, Caldwell previously held various significant roles, including Board of Directors at Belharra Therapeutics and Venture Partner at Versant Ventures. Notable leadership positions include President and CEO at Inception Therapeutics and Mistral Therapeutics, as well as Executive Vice President and Chief Scientific Officer at Ardelyx, Inc. Caldwell's educational background includes a PhD in Molecular Pharmacology from Stanford University School of Medicine and a BA in Molecular and Cell Biology from the University of California, Berkeley.